Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil PCA pump vs oxycodone controlled-release tablets for moderate to severe cancer pain
ChiCTR2100042972Phase 4Completed
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Mar 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sufentanil and oxycodone in cancer pain (2 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoint: Pain relief rate. Started Mar 2019; status: completed.
02
Drugs
sufentaniloxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2100042972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042972.